2025 annual financial data
Aardvark Therapeutics 2025 Operating margin
Aardvark Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -62,725,000 USD and net income was -57,591,000 USD.
Operating cash flow was -54,172,000 USD.
Get free Aardvark Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -62,725,000 USD
- Net income
- -57,591,000 USD
- Operating cash flow
- -54,172,000 USD